ALKS

#967
Alkermes plc - Ordinary Shares
42.2 0 USD
+5.66%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
42.10
42.81
Range Annuel
25.16
42.81
Changement quotidien
+5.66%
Changement Mensuel
+24.52%
Evolution sur 6 mois
+44.03%
Changement Annuel
+39.50%
Clôture Précédente
39.9 4
Open
42.4 6
Low
42.1 0
High
42.8 1
Volume
2 644
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 7.03 B
  • Employee 2 050
  • Founded 1987
  • CEO Richard F. PopsRichard F. Pops
  • Website www.alkermes.com
  • Headquarter Ireland
  • FIGI UNKNOWN
  • Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
19.57
ratio cours/chiffre d'affaires
3.2

Alkermes plc - Ordinary Shares

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

Nouvelles